Teng Wei Chen
Director/Board Member presso AIMFINITY INVESTMENT CORP. I
Profilo
Teng Wei Chen is on the board of Aimfinity Investment Corp.
I, Inkstone Feibo Acquisition Corp.
and New-Shine Biomedical Co., Ltd.
He received a doctorate from China Medical University (Taiwan).
Posizioni attive di Teng Wei Chen
Società | Posizione | Inizio |
---|---|---|
AIMFINITY INVESTMENT CORP. I | Director/Board Member | 17/03/2023 |
Inkstone Feibo Acquisition Corp.
Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | Director/Board Member | - |
New-Shine Biomedical Co., Ltd. | Director/Board Member | 01/01/2018 |
Formazione di Teng Wei Chen
China Medical University (Taiwan) | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AIMFINITY INVESTMENT CORP. I | Finance |
Aziende private | 2 |
---|---|
Inkstone Feibo Acquisition Corp.
Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | Finance |
New-Shine Biomedical Co., Ltd. |